11/21
08:30 am
xgn
Innovative Clinical Biomarkers for SLE and RA: Advancing Autoimmune Diagnostics, Upcoming Webinar Hosted by Xtalks
Low
Report
Innovative Clinical Biomarkers for SLE and RA: Advancing Autoimmune Diagnostics, Upcoming Webinar Hosted by Xtalks
11/14
04:37 pm
xgn
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform [Yahoo! Finance]
Low
Report
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform [Yahoo! Finance]
11/14
04:30 pm
xgn
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
Low
Report
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
11/13
04:05 pm
xgn
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Medium
Report
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
11/13
08:36 am
xgn
Exagen Inc. (NASDAQ: XGN) had its "outperform" rating re-affirmed by analysts at William Blair.
Low
Report
Exagen Inc. (NASDAQ: XGN) had its "outperform" rating re-affirmed by analysts at William Blair.
11/13
02:26 am
xgn
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... [Yahoo! Finance]
Low
Report
Exagen Inc (XGN) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth ... [Yahoo! Finance]
11/12
09:53 am
xgn
Exagen GAAP EPS of -$0.28, revenue of $12.5M [Seeking Alpha]
Low
Report
Exagen GAAP EPS of -$0.28, revenue of $12.5M [Seeking Alpha]
11/12
08:00 am
xgn
Exagen Inc. Reports Third Quarter 2024 Results
Medium
Report
Exagen Inc. Reports Third Quarter 2024 Results
11/11
07:33 am
xgn
Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Medium
Report
Exagen Inc (XGN) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
10/29
04:05 pm
xgn
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
Medium
Report
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
10/21
04:05 pm
xgn
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
Low
Report
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
9/27
04:44 am
xgn
Octopus Energy to invest £2bn in UK renewable energy [Yahoo! Finance]
Low
Report
Octopus Energy to invest £2bn in UK renewable energy [Yahoo! Finance]
9/25
05:08 am
xgn
Octopus Energy acquires solar and storage company Exagen Group [Yahoo! Finance]
Medium
Report
Octopus Energy acquires solar and storage company Exagen Group [Yahoo! Finance]
9/13
07:43 am
xgn
Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week [Yahoo! Finance]
Low
Report
Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week [Yahoo! Finance]
9/4
04:05 pm
xgn
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
High
Report
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
8/29
11:48 am
xgn
Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now [Yahoo! Finance]
Low
Report
Bears are Losing Control Over Exagen (XGN), Here's Why It's a 'Buy' Now [Yahoo! Finance]